Peter J. Barris Sells 139,645 Shares of Senseonics Holdings Inc (SENS) Stock
Senseonics Holdings Inc (NYSEAMERICAN:SENS) major shareholder Peter J. Barris sold 139,645 shares of the firm’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $2.63, for a total value of $367,266.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Senseonics Holdings Inc (NYSEAMERICAN:SENS) opened at $2.60 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81. Senseonics Holdings Inc has a 1-year low of $1.26 and a 1-year high of $3.67.
Senseonics (NYSEAMERICAN:SENS) last issued its earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.13). Senseonics had a negative return on equity of 406.72% and a negative net margin of 828.76%. The firm had revenue of $2.10 million for the quarter, compared to analysts’ expectations of $1.51 million. The company’s revenue for the quarter was up 425.0% on a year-over-year basis. research analysts predict that Senseonics Holdings Inc will post -0.54 earnings per share for the current year.
Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded Senseonics from a “sell” rating to a “hold” rating in a report on Tuesday, August 15th. Canaccord Genuity restated a “buy” rating on shares of Senseonics in a report on Thursday, September 28th.
A number of institutional investors and hedge funds have recently modified their holdings of SENS. Raymond James Financial Services Advisors Inc. boosted its holdings in Senseonics by 221.4% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 263,562 shares of the company’s stock worth $474,000 after buying an additional 181,562 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in Senseonics during the second quarter worth about $276,000. LMR Partners LLP bought a new position in Senseonics during the second quarter worth about $177,000. Susquehanna International Group LLP bought a new position in Senseonics during the second quarter worth about $155,000. Finally, Renaissance Technologies LLC bought a new position in Senseonics during the first quarter worth about $111,000. Hedge funds and other institutional investors own 30.66% of the company’s stock.
Senseonics Company Profile
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.